Costs for Childhood and Adolescent Cancer, 90 Days
Costing statement: Suspected cancer
Costing report
COSTAS S
Cost-utility analysis of using nimotuzumab in end
cost-sharing for health care services: an alternative strategy for
Cost-effectiveness research in cancer therapy: a systematic review
Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-
Cost-Effectiveness of Korea`s National Cervical Cancer Screening
Cost-effectiveness of first-line erlotinib in patients with
Cost-effectiveness of chemotherapy for nonsmall
Cost-Effectiveness of 21-Gene Assay in Node-Positive, Early
Cost-effectiveness analysis of pemetrexed and
Cost-Effectiveness Analysis of CT Colonography for Colorectal
Cost-effective use of aprepitant in multiple
Cost-Benefit Analysis for Pathologic Examination of Reduction
Cost Share Exception Policy
Cost of Care for Elderly Cancer Patients in the United States
Cost of Cancer in NSW
Cost of & Access to Molecularly Targeted Therapies
